Windtree Therapeutics logo

Windtree Therapeutics share price today

(WINT)

Windtree Therapeutics share price is $0.32 & ₹27.19 as on 21 Dec 2024, 2.30 'hrs' IST

$0.32

Market is closed - opens 8 PM, 23 Dec 2024

View live Windtree Therapeutics share price in Dollar and Rupees. Guide to invest in Windtree Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Windtree Therapeutics. Get details on the Indian mutual funds that are investing in Windtree Therapeutics. Get Analyst recommendations and forecasts along with all the Windtree Therapeutics's financials.

Windtree Therapeutics share price movements

  • Today's Low: $0.32
    Today's High: $0.34

    Day's Volatility :7.03%

  • 52 Weeks Low: $0.32
    52 Weeks High: $14.75

    52 Weeks Volatility :97.85%

Windtree Therapeutics Returns

PeriodWindtree Therapeutics IncIndex (Russel 2000)
3 Months
-90.66%
0.0%
6 Months
-90.55%
0.0%
1 Year
-97.56%
0.0%
3 Years
-99.98%
-19.7%

Windtree Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.325
Open
$0.3294
Today's High
$0.3413
Today's Low
$0.3173
Market Capitalization
$4.9M
Today's Volume
$473.6K
52 Week High
$14.7487
52 Week Low
$0.3173
Revenue TTM
$0.0
EBITDA
$-24.7M
Earnings Per Share (EPS)
$-19.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-150.8%

How to invest in Windtree Therapeutics from India?

It is very easy for Indian residents to invest directly in Windtree Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Windtree Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Windtree Therapeutics or WINT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Windtree Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Windtree Therapeutics shares which would translate to 2.655 fractional shares of Windtree Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Windtree Therapeutics, in just a few clicks!

Returns in Windtree Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Windtree Therapeutics investment value today

Current value as on today

₹1,99,761

Returns

₹99,761

(+99.76%)

Returns from Windtree Therapeutics Stock

₹97,565 (false-97.56%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Windtree Therapeutics

61%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Windtree Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 61% more investors are searching Windtree Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Windtree Therapeutics

  • Armistice Capital, LLC

    1.75%

  • Morgan Stanley - Brokerage Accounts

    0.04%

  • Tower Research Capital LLC

    0.02%

Analyst Recommendation on Windtree Therapeutics

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Windtree Therapeutics(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Windtree Therapeutics

What analysts predicted

Upside of 2087.5%

Current:

$0.32

Target:

$7.00

Insights on Windtree Therapeutics

  • Price Movement

    In the last 1 month, WINT stock has moved down by -37.1%
  • WINT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 133.0%
  • WINT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 123.0%

Windtree Therapeutics Technicals Summary

Sell

Neutral

Buy

Windtree Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Windtree Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Windtree Therapeutics Inc
-36.34%
-90.55%
-97.56%
-99.98%
-99.99%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Windtree Therapeutics Inc
0.83
NA
0.0
-2.38
-1.51
-0.45
NA
5.9
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Windtree Therapeutics Inc
Sell
$4.9M
-99.99%
0.83
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Windtree Therapeutics

windtree therapeutics, inc. is a biotechnology company focused on developing novel kl4 surfactant therapies for respiratory diseases and other potential applications. windtree’s proprietary technology platform includes a synthetic, peptide-containing surfactant (kl4 surfactant ) that is structurally similar to human pulmonary surfactant — and novel drug-delivery technologies that are being developed to enable noninvasive administration of aerosolized kl4 surfactant. windtree is focused initially on improving the management of respiratory distress syndrome (rds) in premature infants as surfactant therapy has been shown to save lives in this condition. windtree believes that its proprietary technologies may make it possible, over time, to develop a pipeline of kl4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies and, in doing so, potentially deliver a lifetime of hope to patients and their families.
Organization
Windtree Therapeutics
Employees
0
CEO
Mr. Craig E. Fraser
Industry
Biotechnology

Management People of Windtree Therapeutics

NameTitle
Mr. Craig E. Fraser
President, CEO & Chairman
Mr. Eric L. Curtis M.B.A.
Senior VP & COO
Dr. Steven G. Simonson M.D., M.H.S
Senior VP & Chief Medical Officer
Ms. Jamie McAndrew
Senior VP, CFO, Chief Accounting Officer, Controller & Corporate Secretary
Mr. George Cox
Vice President of Technical Operations
Dr. Pratap Paruchuru
Executive Director of Clinical Development
Ms. Tracy Rarick
Head of Operations & Program Management

Important FAQs about investing in Windtree Therapeutics from India :

What is Windtree Therapeutics share price today?

Windtree Therapeutics share price today stands at $0.32, Open: $0.33 ; Previous Close: $0.33 ; High: $0.34 ; Low: $0.32 ; 52 Week High: $14.75 ; 52 Week Low: $0.32. The stock opens at $0.33, after a previous close of $0.33. The stock reached a daily high of $0.34 and a low of $0.32, with a 52-week high of $14.75 and a 52-week low of $0.32.

Can Indians buy Windtree Therapeutics shares?

Yes, Indians can invest in the Windtree Therapeutics (WINT) from India.

With INDmoney, you can buy Windtree Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Windtree Therapeutics at zero transaction cost.

How can I buy Windtree Therapeutics shares from India?

It is very easy to buy Windtree Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Windtree Therapeutics be purchased?

Yes, you can buy fractional shares of Windtree Therapeutics with INDmoney app.

What are the documents required to start investing in Windtree Therapeutics stocks?

To start investing in Windtree Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Windtree Therapeutics

Today’s highest price of Windtree Therapeutics (WINT) is $0.34.

Today’s lowest price of Windtree Therapeutics (WINT) is $0.32.

What is today's market capitalisation of Windtree Therapeutics

Today's market capitalisation of Windtree Therapeutics WINT is 4.9M

What is the 52 Week High and Low Range of Windtree Therapeutics

  • 52 Week High

    $14.75

  • 52 Week Low

    $0.32

What are the historical returns of Windtree Therapeutics?

  • 1 Month Returns

    -36.34%

  • 3 Months Returns

    -90.55%

  • 1 Year Returns

    -97.56%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Windtree Therapeutics

Mr. Craig E. Fraser is the current Chief Executive Officer (CEO) of Windtree Therapeutics.